Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-10-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0883-0185
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-35
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:2102903-Animals,
pubmed-meshheading:2102903-Autoimmune Diseases,
pubmed-meshheading:2102903-Binding, Competitive,
pubmed-meshheading:2102903-Histocompatibility Antigens,
pubmed-meshheading:2102903-Humans,
pubmed-meshheading:2102903-Lymphocyte Activation,
pubmed-meshheading:2102903-Peptides,
pubmed-meshheading:2102903-T-Lymphocytes
|
pubmed:year |
1990
|
pubmed:articleTitle |
Inhibition of T cell activation by MHC blockade.
|
pubmed:affiliation |
Sandoz Pharma Ltd., Basel, Switzerland.
|
pubmed:publicationType |
Journal Article,
Review
|